paxilline has been researched along with Hepatopulmonary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cui, J; Gu, J; Li, Y; Lu, K; Wang, Z; Yi, B | 1 |
| Chen, B; Chen, Y; Gu, J; Lu, K; Wang, Z; Wen, X; Yang, Y; Yi, B; Zeng, J | 1 |
2 other study(ies) available for paxilline and Hepatopulmonary Syndrome
| Article | Year |
|---|---|
Paxillin suppresses the proliferation of HPS rat serum treated PASMCs by up-regulating the expression of cytoskeletal proteins.
Topics: Actins; Animals; Cell Proliferation; Cytoskeletal Proteins; Destrin; Down-Regulation; Hepatopulmonary Syndrome; Lung; Muscle, Smooth, Vascular; Paxillin; Pulmonary Artery; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Messenger; RNA, Small Interfering; Serum; Signal Transduction; Tubulin | 2014 |
Annexin A2 inhibits the migration of PASMCs stimulated with HPS rat serum by down-regulating the expression of paxillin.
Topics: Animals; Annexin A2; Cell Movement; Cells, Cultured; Down-Regulation; Hepatopulmonary Syndrome; Myocytes, Smooth Muscle; Paxillin; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Serum | 2016 |